semaglutide news today 2025 ReflexMD Reviews 2025: Is It Worth the Hype?

FDA has approved a new oral form of semaglutide for long-term weight reduction in adults with obesity or overweight. The new oral tablet is also indicated for reducing the risk of major

20.32

★★★★☆4.8 (126)

Scientists find Ozempic may treat cancer, Alzheimer's and more. Is it hype or truly a "wonder drug?"

27.47

★★★★★4.9 (98)

The Trump administration is preparing to launch a pilot program that would cover weight loss drugs like Ozempic and Wegovy through Medicare and Medicaid. This could be a game-changer for millions of

24.12

★★★★★5.0 (157)

Medicare, Medicaid to experiment with covering weight loss drugs

25.85

★★★★★4.7 (84)

In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintide–semaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial results

21.46

★★★★★4.9 (203)

To count down the New Year, we are revisiting the top 10 stories you've most enjoyed in 2025! Next up, researchers found that weight loss drugs like semaglutide may shrink heart muscle

21.84

★★★★★5.0 (176)

The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25

27.14

★★★★★4.8 (132)